Le Lézard
Classified in: Health
Subject: SVY

Global $884 Mn Next-Generation Surgical Robotics Market, 2020-2030: Product Analysis, Regulatory Scenario, Key Enabling Technologies, Patent Analysis


DUBLIN, Oct. 29, 2020 /PRNewswire/ -- The "Global Next-Generation Surgical Robotics Market: Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The market size of next-generation surgical robotics was valued at $10.9 million in 2019. The global next-generation surgical robotics market is expected to grow at a robust rate. It is anticipated to reach $884.5 million in 2030 with a CAGR of 44.6% during the forecast period 2020-2030.

The market contributors for next-generation surgical robotics predominantly prefer synergistic activities, such as partnerships and collaborations, to strengthen their product development and commercialization processes. Moreover, many key players are collaborating with academic research institutes to gain expertise in the technology.

The global next-generation surgical robotics market specific to the application (general surgery) is anticipated to witness a notable CAGR of 52.2% during the forecast period, 2020-2030.

This market intelligence report provides a multidimensional view of the global next-generation surgical robotics market in terms of market size and growth potential. This research report aims to answer various aspects of the tissue imaging market with the help of the key factors driving the market, threats that can inhibit the overall market growth, and the current growth opportunities that will shape the future trajectory of market expansion.

Furthermore, the competitive landscape chapter in the report illustrates the competitive nature of the global market. It enables the reader to get acquainted with the recent market activities such as business portfolio expansions, partnerships, and acquisitions. The research report provides a comprehensive analysis of the service sales, and manufacturers and trend analysis by segments, such as technology, product type, application, and region.

This report is a meticulous compilation of research on ten players in the market ecosystem. It draws upon insights from in-depth interviews with the key opinion leaders of the leading companies, market participants, and vendors. The report also profiles ten companies, including key players, i.e., Activ Surgical, Inc., AVRA Medical Robotics, Inc., CMR Surgical Ltd., Corindus Vascular Robotics, Inc. (Siemens Healthineers AG), Memic Innovative Surgery Ltd., Microbot Medical, Inc., PROCEPT BioRobotics Corporation, Vicarious Surgical Inc., Virtual Incision Corporation, and Virtuoso Surgical, Inc.

Key Topics Covered:

1 Technology Definition

2 Scope of Research Study

3 Research Methodology

4 Industry Analysis
4.1 Global Next-Generation Surgical Robotics Market Overview
4.2 Product Analysis
4.3 Regulatory Scenario
4.3.1 U.S.
4.3.2 Europe
4.3.2.1 Impact of the EU's Medical Device Regulations (MDR)
4.3.2.1.1 Expansion of Product Scope
4.3.2.1.2 Reclassification of Medical Devices as per Associated Risk, Contact Duration, and Invasiveness
4.3.2.1.3 More Supportive Clinical Investigations for Class III and Implantable Medical Devices
4.3.2.1.4 Dedicated Personal for MDR Compliance
4.3.2.1.5 More Emphasis on Post-Market Surveillance
4.3.2.1.6 Requirement of Common Specifications
4.3.2.1.7 Implementation of a Unique Device Identification (UDI) Mechanism
4.3.3 Japan
4.3.4 China
4.4 Key Enabling Technologies
4.4.1 Haptics: Re-Establishing the Lost Connect Between Surgeon and Patient
4.4.2 Artificial Intelligence: A Technological Paradigms in Surgical Robotics
4.5 Case Studies of Few Novel Concepts
4.6 Patent Analysis
4.6.1 Patent Filing Trend
4.6.2 Patent Filing Trend, by Technology
4.6.3 Patent Filing Trend, by Country
4.6.4 CPC Codes
4.6.5 Patent Landscape - Miniaturized Surgical Robotics
4.6.6 Patent Landscape - Autonomous Surgical Robotics
4.6.7 Patent Landscape - Teleoperated Surgical Robotics
4.6.8 Key Innovative Patents

5 Competitive Landscape
5.1 Key Developments and Strategies
5.1.1 Partnerships, Alliances, and Business Expansions Activities
5.1.2 Funding Activities
5.1.3 Regulatory and Legal
5.1.4 Mergers and Acquisitions
5.1.5 New Offerings
5.2 Market Share Analysis
5.3 Growth Share Analysis

6 Global Next-Generation Surgical Robotics Market Scenario
6.1 Limitations and Assumptions
6.2 Key Findings
6.3 Potential Opportunities
6.3.1 Development of Low-Cost Next-Generation Surgical Systems
6.3.2 Development of Surgical Simulators for Training
6.4 Market Dynamics
6.4.1 Overview
6.4.2 Impact Analysis
6.4.3 Market Drivers
6.4.3.1 Rising Prevalence of Chronic Disorders Inciting the Use of Robotic-Assisted Surgeries
6.4.3.2 Elevating Elderly Population: A Shifting Trend Toward More Minimally Invasive Surgeries
6.4.3.3 Increasing Healthcare Expenditure in Developing Countries Expected to Increase Uptake of Next-Generation Surgical Robotics Technologies
6.4.3.4 Increasing Demand for Minimally Invasive Surgeries Signifies the Need for Next-Generation Surgical Robotics
6.4.3.5 Low Cost of Next-Generation Surgical Robotic Platforms
6.4.4 Market Restraints
6.4.4.1 Lack of Skilled Professionals
6.4.4.2 Restrictive Reimbursement Framework

7 Global Next-Generation Surgical Robotics Market (by Technology), 2019-2030
7.1 Market Overview
7.2 Miniaturized Surgical Robotics
7.3 Autonomous Surgical Robotics
7.4 Teleoperated Surgical Robotics

8 Global Next-Generation Surgical Robotics Market (by Application), 2019-2030
8.1 Market Overview
8.2 General Surgery
8.3 Urology Surgery
8.4 Aesthetic Surgery
8.5 Cardiology Surgery
8.6 Gynecology Surgery
8.7 Neurology Surgery

9 Global Next-Generation Surgical Robotics Market (by Region), 2019-2030

10 Company Profiles
10.1 Company Overview
10.2 Role of the Company in the Next-Generation Surgical Robotics Market
10.3 Product Roadmap
10.4 Revenue Estimation
10.5 SWOT Analysis

For more information about this report visit https://www.researchandmarkets.com/r/ngfxod

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 18:32
Pomerantz LLP announces that a class action lawsuit has been filed against Mesoblast Limited ("Mesoblast" or the "Company") and certain of its officers.   The class action, filed in United States District Court for the Southern District of New York,...

at 18:05
GlycoMimetics' product candidate uproleselan ? when added to a combination therapy of venetoclax and a hypomethylating agent (HMA) ? was shown today in an oral presentation to break chemoresistance by dramatically and significantly reducing tumor...

at 18:00
Quanta X Technology, the parent company of QuantaDose, CEO Katie Webb suggests, "Anyone in Santa's shoes gifting a UVC device to a friend or family member needs to make sure the UV-C device is real, and they also need to understand the potential...

at 17:00
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial data for the Phase 1 first-in-human dose escalation study of talquetamab (JNJ-64407564) for the treatment of relapsed or refractory multiple myeloma (NCT03399799)....

at 17:00
63% response rate in patients treated with the highest reported dose Among all patients responding to treatment, 95% experienced a very good partial response or better; among responding patients with ?6 months of follow-up, 83% have ongoing responses...

at 16:55
Eunice Wang, MD, Chief of Leukemia and Director of Infusion Services at Roswell Park Comprehensive Cancer Center, is leading multiple research efforts focused on different treatment approaches for acute myeloid leukemia (AML) patients. Today, during...



News published on 29 october 2020 at 15:00 and distributed by: